Healthcare provider profile · identity verified

Laura Bagley, MD

Family Practice · INVER GROVE HEIGHTS, MN · NPI 1245642271

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	535	148
Losartan Potassium	Losartan Potassium	363	100
Amlodipine Besylate	Amlodipine Besylate	352	95
Lisinopril	Lisinopril	342	94
Omeprazole	Omeprazole	296	93
Levothyroxine Sodium	Levothyroxine Sodium	291	72
Hydrochlorothiazide	Hydrochlorothiazide	249	71
Simvastatin	Simvastatin	209	52
Gabapentin	Gabapentin	199	59
Metformin Hcl	Metformin Hcl	161	40
Metoprolol Succinate	Metoprolol Succinate	157	47
Trazodone Hcl	Trazodone Hcl	135	44
Zolpidem Tartrate	Zolpidem Tartrate	131	17
Tamsulosin Hcl	Tamsulosin Hcl	124	33
Sertraline Hcl	Sertraline Hcl	122	34
Rosuvastatin Calcium	Rosuvastatin Calcium	121	32
Furosemide	Furosemide	118	40
Albuterol Sulfate Hfa	Albuterol Sulfate	111	47
Allopurinol	Allopurinol	110	29
Alendronate Sodium	Alendronate Sodium	104	31
Atenolol	Atenolol	104	25
Escitalopram Oxalate	Escitalopram Oxalate	103	33
Oxycodone Hcl	Oxycodone Hcl	99	20
Tramadol Hcl	Tramadol Hcl	97	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	93	29
Lorazepam	Lorazepam	93	20
Famotidine	Famotidine	86	25
Fluticasone Propionate	Fluticasone Propionate	81	32
Metformin Hcl Er	Metformin Hcl	80	26
Pantoprazole Sodium	Pantoprazole Sodium	80	24
Citalopram Hbr	Citalopram Hydrobromide	70	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	67	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	66	suppressed
Alprazolam	Alprazolam	65	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	64	13
Prednisone	Prednisone	64	37
Bupropion Xl	Bupropion Hcl	63	19
Ozempic	Semaglutide	62	15
Fluoxetine Hcl	Fluoxetine Hcl	61	17
Metoprolol Tartrate	Metoprolol Tartrate	58	16
Glipizide Er	Glipizide	56	18
Warfarin Sodium	Warfarin Sodium	54	15
Duloxetine Hcl	Duloxetine Hcl	51	14
Valacyclovir	Valacyclovir Hcl	51	20
Clopidogrel	Clopidogrel Bisulfate	49	14
Glipizide	Glipizide	47	13
Sumatriptan Succinate	Sumatriptan Succinate	47	suppressed
Buspirone Hcl	Buspirone Hcl	46	suppressed
Potassium Chloride	Potassium Chloride	46	15
Paroxetine Hcl	Paroxetine Hcl	45	12
Pravastatin Sodium	Pravastatin Sodium	43	12
Venlafaxine Hcl Er	Venlafaxine Hcl	43	suppressed
Meloxicam	Meloxicam	42	18
Oxybutynin Chloride Er	Oxybutynin Chloride	42	12
Amitriptyline Hcl	Amitriptyline Hcl	41	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	41	12
Donepezil Hcl	Donepezil Hcl	40	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	38	15
Acetaminophen-Codeine	Acetaminophen With Codeine	37	suppressed
Memantine Hcl	Memantine Hcl	36	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	36	12
Pregabalin	Pregabalin	36	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	35	11
Triamcinolone Acetonide	Triamcinolone Acetonide	34	22
Hydralazine Hcl	Hydralazine Hcl	33	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	suppressed
Cephalexin	Cephalexin	32	18
Montelukast Sodium	Montelukast Sodium	32	suppressed
Tizanidine Hcl	Tizanidine Hcl	32	suppressed
Chlorthalidone	Chlorthalidone	31	suppressed
Jantoven	Warfarin Sodium	31	suppressed
Ondansetron Odt	Ondansetron	30	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Carvedilol	Carvedilol	28	suppressed
Mirtazapine	Mirtazapine	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Finasteride	Finasteride	25	suppressed
Irbesartan	Irbesartan	25	suppressed
Lovastatin	Lovastatin	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	20
Propranolol Hcl	Propranolol Hcl	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Fluconazole	Fluconazole	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Jardiance	Empagliflozin	19	suppressed
Eliquis	Apixaban	18	suppressed
Topiramate	Topiramate	17	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	suppressed
Nitroglycerin	Nitroglycerin	16	13
Ibuprofen	Ibuprofen	15	suppressed
Naltrexone Hcl	Naltrexone Hcl	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	11
Januvia	Sitagliptin Phosphate	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Dulera	Mometasone/Formoterol	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	13	suppressed
Torsemide	Torsemide	13	suppressed
Dilantin	Phenytoin Sodium Extended	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Risperidone	Risperidone	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Diazepam	Diazepam	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Naproxen	Naproxen	11	suppressed
Nystatin	Nystatin	11	suppressed
Ramipril	Ramipril	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error